Pharma Times

NOVEMBER 11, 2021

ChAdOxl biEBOV is being tested for safety and immunogenicity, and may protect against multiple species of the virus

Vaccines 176

Vaccines 176

pharmaphorum

NOVEMBER 12, 2021

Researchers in the US have developed an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest which FDA-approved drugs might be used to treat patients. The MOATAI-VIR algorithm, developed by scientists at Emory University and Georgia Tech, was put through its paces in a study that showed it was able to predict 24 out of 26 clinical manifestations of COVID-19, including acute respiratory distress, blood clotting issues, cytokine storms, brain fog, and loss of sm

Diabetes 135

Diabetes Immunization Immunity 135

Drug Patent Watch

NOVEMBER 10, 2021

Annual Drug Patent Expirations for ARISTADA+INITIO+KIT Aristada Initio Kit is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Alkermes Inc drug ARISTADA INITIO KIT appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Outsourcing Pharma

NOVEMBER 10, 2021

Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.

98

98

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

NOVEMBER 12, 2021

Researchers have said that next generation vaccines for COVID-19 should aim to induce a response against ‘replication proteins’

Vaccines 152

Vaccines 152

Drug Patent Watch

NOVEMBER 9, 2021

This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2016 to 2021. Companies that successfully challenge patents on branded drugs are granted six…. The post Most prolific drug patent challengers appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

NY Times

NOVEMBER 9, 2021

Moderna’s patent application names several employees as the sole inventors of a crucial component of its coronavirus vaccine, excluding three government scientists.

Vaccines 91

Vaccines Immunization Immunity 91

Pharma Times

NOVEMBER 10, 2021

Janssen's Ponvory accepted for use within NHS Scotland for adults RRMS patients

150

150

pharmaphorum

NOVEMBER 9, 2021

Scotland has given the green light to AstraZeneca’s Tagrisso for restricted use to treat adult patients with non-small cell lung cancer (NSCLC), making it the first country in the world to approve the routine use of the therapy in this setting. The Scottish Medicines Consortium (SMC) has approved Tagrisso (osimertinib) for use within NHS Scotland as a monotherapy for adjuvant treatment after tumour removal in adult patients with stage IB-IIIA NSCLC whose tumours have epidermal growth factor (EGF

Chemotherapy 105

Chemotherapy 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Outsourcing Pharma

NOVEMBER 11, 2021

During our November 17 webinar Patient-centric solutions, a group of professionals representing a range of perspectives will share ideas and innovations.

88

88

Drug Channels

NOVEMBER 9, 2021

The Food & Drug Administration (FDA) recently approved the first interchangeable biosimilar insulin product: the insulin glargine-yfgn injection from Viatris. Read the FDA’s press release. Alas, I’m sad to report that the warped incentives baked into the U.S. drug channel will limit the impact of this impressive breakthrough. Viatris is being forced to launch both a high-priced and a low-priced version of the biosimilar.

Biosimilars 75

Biosimilars Drug Pricing 75

Pharma Times

NOVEMBER 9, 2021

Funding proceeds will be used to support ongoing trials of Gyroscopes investigational gene therapy GT005

148

148

pharmaphorum

NOVEMBER 8, 2021

A single dose of the COVID-19 monoclonal antibody therapy developing Regeneron reduced the risk of contracting the virus by around 82% for up to eight months, according to new trial data. The results suggest that the REGEN-COV (casirivimab/imdevimab) antibody could play a key role in protecting people who do not mount a sufficiently strong immune response after COVID-19 vaccines, according to the company.

Vaccines 105

Vaccines Immunization Immunity Hospitals 105

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Outsourcing Pharma

NOVEMBER 12, 2021

Johnson & Johnson today announced its intent to separate its Consumer Health business into a new publicly traded company: allowing J&J to put a sharpened focus on pharmaceuticals and medical devices.

85

85

Drug Channels

NOVEMBER 8, 2021

Informa Connect’s Trade & Channel Strategies. Delivered as a Hybrid Event In-Person: December 13-14, 2021, Hilton Philadelphia at Penn’s Landing, Philadelphia, PA Virtual: December 16-17, 2021 [link]. The full agenda for this year’s Trade and Channel Strategies conference is available now! Year after year, the life science industry marks Informa Connect’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals.

Specialty Pharmacies 75

Specialty Pharmacies Biosimilars 75

Pharma Times

NOVEMBER 9, 2021

iiCON’s lead partner LSTM will independently validate CN Bio’s novel lung and lung-liver models

142

142

pharmaphorum

NOVEMBER 10, 2021

Tackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and environmental drivers, consequences, and data. AMR threatens to undermine “almost a century of health gains” and marshalling a response to such a problem “requires cooperation at many levels”. That’s according to a newly published report from the US National Academies of Sciences, Engineering, and Medicine, which calls for a One Health approach that recognises the scale of th

Hospitals 105

Hospitals Nursing Homes Pharmaceutical Companies Pharmaceutical Companies 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

NY Times

NOVEMBER 12, 2021

The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.

73

73

Pharma Marketing Network

NOVEMBER 8, 2021

November 3, 2021 – Tune in with the Pharma Marketing Network for an exciting conversation with R.J. Lewis and David Hunt, CEO of The Considered, as he shares how his new independent agency, The Considered, about how they are breaking the rules in pharma advertising. David discusses and answers questions around: How The Considered is different. What launched the conception of the agency?

72

72

Pharma Times

NOVEMBER 10, 2021

The new research by Heriot-Watt University has identified a way of targeting an enzyme called EPAC1

133

133

pharmaphorum

NOVEMBER 11, 2021

Shares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its COVID-19 vaccine VLA2001 over the next two years, including 27 million next year. The deal for the adjuvanted, inactivated SARS-CoV-2 vaccine still depends on authorisation of the jab by the European Medicines Agency (EMA) which is due to start a rolling review of VLA2001 shortly, but Valneva thinks it could start delivering supplies to the EU in April next year.

Vaccines 105

Vaccines 105

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Outsourcing Pharma

NOVEMBER 8, 2021

The decentralized tech specialist has acquired Digital Artefacts, a research tech firm focused on cognitive, behavioral, and physiological data capture.

72

72

NY Times

NOVEMBER 9, 2021

The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.

64

64

Pharma Times

NOVEMBER 12, 2021

The draft guidance has been published following an evaluation of new evidence on the use of the treatment

130

130

pharmaphorum

NOVEMBER 10, 2021

After being hailed as a triumph of public-private drug development, Moderna’s partnership with the US government on its COVID-19 vaccine looks like it may descend into acrimony. That is according to a New York Times report , which says Moderna is now in dispute with the National Institutes of Health (NIH) after it filed a US patent in the US that claims the company’s scientists invented the vaccine on their own.

Vaccines 105

Vaccines Documentation Drug Development 105

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Outsourcing Pharma

NOVEMBER 10, 2021

According to the market intelligence firm, automation appeals to drug packaging and manufacturing firms, thanks to their productivity-boosting potential.

Packaging 69

Packaging 69

NY Times

NOVEMBER 12, 2021

Countries have been paying about $3 to $4 per shot for AstraZeneca’s vaccine under the company’s not-for-profit pricing model.

Vaccines 56

Vaccines Immunization Immunity 56

Pharma Times

NOVEMBER 11, 2021

Decision follows the UK government’s termination of their deal with Valneva in September

130

130